Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH or Institute), 75922-75923 [2013-29745]
Download as PDF
<![CDATA[
75922
Federal Register / Vol. 78, No. 240 / Friday, December 13, 2013 / Notices
We are also requesting a title change to
read—Import Permit Applications (42
CFR 71.54).
The Application for Permit to Import
Biological Agents, Infectious Substances
and Vectors of Human Disease into the
United States form is used by laboratory
facilities, such as those operated by
government agencies, universities, and
research institutions to request a permit
for the importation of biological agents,
infectious substances, or vectors of
human disease. This form currently
requests applicant and sender contact
information; description of material for
importation; facility isolation and
containment information; and personnel
qualifications. CDC plans to revise this
application to request information on
where the imported material will be
stored at the recipient facility and who
would be responsible for this location;
verification that the permittee has
implemented biosafety measures
commensurate with the hazard posed by
the infectious biological agent,
infectious substance, and/or vector to be
imported, and the level of risk given its
intended use; and a secondary contact
information for the permittee to provide
in case the permittee is unavailable.
These additional data requests will not
affect the burden hours.
The Application for Permit to Import
or Transport Live Bats form is used by
laboratory facilities such as those
operated by government agencies,
universities, research institutions, and
for educational, exhibition or scientific
purposes to request a permit for the
importation, and any subsequent
distribution after importation, of live
bats. This form currently requests the
applicant and sender contact
information; a description and intended
use of bats to be imported; and facility
isolation and containment information.
CDC plans to revise this application to
request secondary contact information
for the permittee to provide in case the
permittee is unavailable. These
additional data requests will not affect
the burden hours.
Estimates of burden for the survey are
based on information obtained from the
CDC import permit database based on
the number of permits issued on annual
basis since 2010. The total estimated
annual burden for the data collection is
545 hours. We estimate a decrease in the
number of respondents from 2,000 in
2011 to 1,625 due to recent trends and
changes in the regulation. The daily
operations have observed a decrease in
the number of request for an import
permit since 2011. In addition, the
changes in 42 CFR 71.54, which became
effective April 5, 2013, specify
situations where an application for a
permit is no longer required. For
example, the importation of a select
agent that is regulated under 42 CFR
Part 73 no longer requires a permit be
issued.
There are no costs to respondents
except their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Applicants Requesting to Import Biological
Agents, Infectious Substances and Vectors.
Applicants Requesting to Import Live Bats ....
Application for Permit to Import Infectious Biological Agents into the United States.
Application for a Permit to Import Live Bats ..
LeRoy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2013–29742 Filed 12–12–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
ehiers on DSK2VPTVN1PROD with NOTICES
Safety and Occupational Health Study
Section (SOHSS), National Institute for
Occupational Safety and Health
(NIOSH or Institute)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Times and Dates:
8:00 a.m.–5:00 p.m., February 19, 2014
(Closed)
8:00 a.m.–5:00 p.m., February 20, 2014
(Closed)
VerDate Mar<15>2010
13:32 Dec 12, 2013
Jkt 232001
8:00 a.m.–5:00 p.m., February 21, 2014
(Closed)
Place: Embassy Suites, 1900 Diagonal
Road, Alexandria, Virginia 22314,
Telephone: (703) 684–5900, Fax: (703)
684–0653.
Purpose: The Safety and Occupational
Health Study Section will review,
discuss, and evaluate grant
application(s) received in response to
the Institute’s standard grants review
and funding cycles pertaining to
research issues in occupational safety
and health, and allied areas.
It is the intent of NIOSH to support
broad-based research endeavors in
keeping with the Institute’s program
goals. This will lead to improved
understanding and appreciation for the
magnitude of the aggregate health
burden associated with occupational
injuries and illnesses, as well as to
support more focused research projects,
which will lead to improvements in the
delivery of occupational safety and
health services, and the prevention of
work-related injury and illness. It is
anticipated that research funded will
promote these program goals.
Matters to Be Discussed: The meeting
will convene to address matters related
PO 00000
Frm 00013
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hrs.)
1,625
1
20/60
10
1
20/60
to the conduct of Study Section
business and for the study section to
consider safety and occupational healthrelated grant applications.
These portions of the meeting will be
closed to the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, Centers for Disease Control and
Prevention, pursuant to Section 10(d)
Public Law 92–463.
Agenda items are subject to change as
priorities dictate.
Contact Person For More Information:
Price Connor, Ph.D., NIOSH Health
Scientist, CDC, 2400 Executive Parkway,
Mailstop E–20, Atlanta, Georgia 30345,
Telephone: (404) 498–2511, Fax: (404)
498–2571.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
E:\FR\FM\13DEN1.SGM
13DEN1
Federal Register / Vol. 78, No. 240 / Friday, December 13, 2013 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–29745 Filed 12–12–13; 8:45 am]
[FR Doc. 2013–29750 Filed 12–12–13; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
ehiers on DSK2VPTVN1PROD with NOTICES
Prevention and the Agency for Toxic
Substances and Disease Registry.
Advisory Committee on Breast Cancer
in Young Women (ACBCYW)
The meeting announced below
concerns Clinical, Epidemiologic and
Ecologic Factors Impacting the Burden
and Distribution of Monkeypox in
Tshuapa District, Democratic Republic
of the Congo, Funding Opportunity
Announcement (FOA) CK14–002, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time And Date: 1:00 p.m.–3:00 p.m.,
February 18, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters To Be Discussed: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Clinical, Epidemiologic and Ecologic
Factors Impacting the Burden and
Distribution of Monkeypox in Tshuapa
District, Democratic Republic of the
Congo, FOA CK14–002’’.
Contact Person For More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE., Mailstop E60, Atlanta,
Georgia 30333, Telephone: (404) 718–
8833.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
VerDate Mar<15>2010
13:32 Dec 12, 2013
Jkt 232001
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 9:00 a.m.–3:00 p.m.
EST, January 9, 2014.
Place: The meeting will be held via
Teleconference.
Limited teleconference access is also
available. Teleconference login
information is as follows:
For Public:
TOLL–FREE PHONE #: 888–989–8135
Participant passcode: BREASTCANCER
or 273278226237
For Public:
Net Conference URL: https://www.my
meetings.com/nc/join/
Conference number: PW3233834
Audience passcode: BREASTCANCER
or
Public can join the event directly at:
https://www.mymeetings.com/nc/join.
php?i=PW3233834&p=BREAST
CANCER&t=c.
There is also a toll free number for
anyone outside of the USA: TOLL #: 1–
203–827–7034.
Participant passcode:
BREASTCANCER or 273278226237.
Status: Open to the public, limited
only by the net conference and audio
phone lines available.
Purpose: The committee provides
advice and guidance to the Secretary,
HHS; the Assistant Secretary for Health;
and the Director, CDC, regarding the
formative research, development,
implementation and evaluation of
evidence-based activities designed to
prevent breast cancer (particularly
among those at heightened risk) and
promote the early detection and support
of young women who develop the
disease. The advice provided by the
Committee will assist in ensuring
scientific quality, timeliness, utility, and
PO 00000
Frm 00014
Fmt 4703
Sfmt 4703
75923
dissemination of credible appropriate
messages and resource materials.
Matters To Be Discussed: The agenda
will include discussions on the current
and emerging topics related to breast
cancer in young women. These may
include risk communication and health
education, as well as approaches to
increase awareness of clinicians/
practitioners regarding topics such as
breast cancer risk, breast health,
symptoms, diagnosis, and treatment of
breast cancer in young women.
Agenda items are subject to change as
priorities dictate.
Online Registration Required: All
ACBCYW Meeting participants must
register for the meeting online at least 5
days in advance at https://www.cdc.gov/
cancer/breast/what_cdc_is_doing/
meetings.htm. Please complete all the
required fields before submitting your
registration and submit no later than
January 5, 2014.
Contact Person For More Information:
Temeika L. Fairley, Ph.D., Designated
Federal Officer, National Center for
Chronic Disease Prevention and Health
Promotion, CDC, 4770 Buford Highway
NE., Mailstop K52, Atlanta, Georgia
30341, Telephone (770) 488–4518, Fax
(770) 488–4760 Email: acbcyw@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–29749 Filed 12–12–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC)
Office for State, Tribal, Local and
Territorial Support (OSTLTS)
In accordance with Presidential
Executive Order No. 13175, November
6, 2000, and the Presidential
Memorandum of November 5, 2009, and
September 23, 2004, Consultation and
Coordination with Indian Tribal
Governments, CDC/Agency for Toxic
Substances and Disease Registry
(ATSDR), announces the following
meeting and Tribal Consultation
Session:
E:\FR\FM\13DEN1.SGM
13DEN1
]]>Agencies
[Federal Register Volume 78, Number 240 (Friday, December 13, 2013)]
[Notices]
[Pages 75922-75923]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-29745]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Safety and Occupational Health Study Section (SOHSS), National
Institute for Occupational Safety and Health (NIOSH or Institute)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Times and Dates:
8:00 a.m.-5:00 p.m., February 19, 2014 (Closed)
8:00 a.m.-5:00 p.m., February 20, 2014 (Closed)
8:00 a.m.-5:00 p.m., February 21, 2014 (Closed)
Place: Embassy Suites, 1900 Diagonal Road, Alexandria, Virginia
22314, Telephone: (703) 684-5900, Fax: (703) 684-0653.
Purpose: The Safety and Occupational Health Study Section will
review, discuss, and evaluate grant application(s) received in response
to the Institute's standard grants review and funding cycles pertaining
to research issues in occupational safety and health, and allied areas.
It is the intent of NIOSH to support broad-based research endeavors
in keeping with the Institute's program goals. This will lead to
improved understanding and appreciation for the magnitude of the
aggregate health burden associated with occupational injuries and
illnesses, as well as to support more focused research projects, which
will lead to improvements in the delivery of occupational safety and
health services, and the prevention of work-related injury and illness.
It is anticipated that research funded will promote these program
goals.
Matters to Be Discussed: The meeting will convene to address
matters related to the conduct of Study Section business and for the
study section to consider safety and occupational health-related grant
applications.
These portions of the meeting will be closed to the public in
accordance with provisions set forth in Section 552b(c)(4) and (6),
Title 5 U.S.C., and the Determination of the Director, Management
Analysis and Services Office, Centers for Disease Control and
Prevention, pursuant to Section 10(d) Public Law 92-463.
Agenda items are subject to change as priorities dictate.
Contact Person For More Information: Price Connor, Ph.D., NIOSH
Health Scientist, CDC, 2400 Executive Parkway, Mailstop E-20, Atlanta,
Georgia 30345, Telephone: (404) 498-2511, Fax: (404) 498-2571.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and
[[Page 75923]]
Prevention and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2013-29745 Filed 12-12-13; 8:45 am]
BILLING CODE 4163-18-P
